FDA Grants Premarket Approval (PMA) for the NeuroPace RNS® System to treat Medically Refractory Epilepsy — November 14, 2013

FDA Grants Premarket Approval (PMA) for the NeuroPace RNS® System to treat Medically Refractory Epilepsy — November 14, 2013

By November 14, 2013 December 12th, 2016 Archived Press Release, Press Release